Obesidad y Síndrome de Ovario Poliquístico en Edad Fértil
Resumen
Las féminas en edad fértil que padecen obesidad y síndrome de ovario poliquístico (SOP) tienen una relación complicada que repercute enormemente en su salud metabólica y reproductiva. A través de un análisis exhaustivo de la literatura científica publicada entre 2020 y 2024, este estudio pretende comprender este vínculo. El estudio se recopiló a partir de fuentes reputadas como PubMed y Google Scholar utilizando una metodología descriptiva y cualitativa. Según las conclusiones, la obesidad agrava los síntomas del SOP, como la resistencia a la insulina, el hiperandrogenismo y la inflamación crónica, aumentando el riesgo de problemas cardiovasculares y reproductivos. Las intervenciones más eficaces se distinguen por su carácter integral, que incorpora estrategias de control del peso, ajustes del estilo de vida, tratamiento farmacológico (metformina y agonistas del GLP-1) y planes dietéticos específicos. Se destaca que para mejorar los indicadores metabólicos y hormonales es necesario un primer descenso del peso corporal del 5-10%. Esta investigación pone de relieve la importancia de las terapias personalizadas para mejorar los resultados clínicos y la calidad de vida de las mujeres con obesidad y SOP.
Descargas
Citas
Almawi, W. Y., Nemr, R., Atazhanova, T., Malalla, Z. H., Sarray, S., Mustafa, F. E., & Mahmood, N. A. (2023). Differential Association of FTO Gene variants and Haplotypes with the Susceptibility to Polycystic Ovary Syndrome According To Obesity in Women with PCOS. Reproductive Sciences, 30(7), 2166-2176. https://doi.org/10.1007/s43032-022-01149-w
Alnafjan, A. A., Alkhuriji, A. F., Alobaid, H. M., Babay, Z. A., & Khalil, M. I. (2022). Association of FTO gene variants rs9939609 and rs1421085 with polycystic ovary syndrome. Egyptian Journal Of Medical Human Genetics, 23(1). https://doi.org/10.1186/s43042-022-00263-3
Barber, T. M. (2022a). Why are women with polycystic ovary syndrome obese? British Medical Bulletin, 143(1), 4-15. https://doi.org/10.1093/bmb/ldac007
Barber, T. M. (2022b). Why are women with polycystic ovary syndrome obese? British Medical Bulletin, 143(1), 4-15. https://doi.org/10.1093/bmb/ldac007
Barber, T. M., & Franks, S. (2021). Obesity and polycystic ovary syndrome. Clinical Endocrinology, 95(4), 531-541. https://doi.org/10.1111/cen.14421
Begum, R. F., S, A. S., & Mohan, S. (2023). Impact of junk food on obesity and polycystic ovarian syndrome: Mechanisms and management strategies. Obesity Medicine, 40, 100495. https://doi.org/10.1016/j.obmed.2023.100495
Bhattacharya, K., Sengupta, P., Dutta, S., Chaudhuri, P., Mukhopadhyay, L. D., & Syamal, A. K. (2021). Waist-to-height ratio and BMI as predictive markers for insulin resistance in women with PCOS in Kolkata, India. Endocrine, 72(1), 86-95. https://doi.org/10.1007/s12020-020-02555-3
Chudzicka-Strugała, I., Gołębiewska, I., Banaszewska, B., Brudecki, G., & Zwoździak, B. (2022). The Role of Individually Selected Diets in Obese Women with PCOS—A Review. Nutrients, 14(21), 4555. https://doi.org/10.3390/nu14214555
Gnanadass, S. A., Prabhu, Y. D., & Gopalakrishnan, A. V. (2021). Association of metabolic and inflammatory markers with polycystic ovarian syndrome (PCOS): an update. Archives Of Gynecology And Obstetrics, 303(3), 631-643. https://doi.org/10.1007/s00404-020-05951-2
Hayat, F. A., Shahzad, A., Eman, U., Malik, L., Aziz, H., Akbar, S. U. D., Mustafa, G., & Khalid, I. (2024). Differential Prevalence of Depression Symptoms in Obese Versus Non-obese Women with Polycystic Ovary Syndrome. Developmental Medico-life-sciences, 1(3), 27-34. https://doi.org/10.69750/dmls.01.03.033
Itriyeva, K. (2022). The effects of obesity on the menstrual cycle. Current Problems In Pediatric And Adolescent Health Care, 52(8), 101241. https://doi.org/10.1016/j.cppeds.2022.101241
Jiang, H., Chen, L., Tian, T., Shi, H., Huang, N., Chi, H., Yang, R., Long, X., & Qiao, J. (2023). Inflammation mediates the effect of adiposity and lipid metabolism indicators on the embryogenesis of PCOS women undergoing in vitro fertilization/intracytoplasmic sperm injection. Frontiers In Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1198602
Kałużna, M., Człapka-Matyasik, M., Wachowiak-Ochmańska, K., Moczko, J., Kaczmarek, J., Janicki, A., Piątek, K., Ruchała, M., & Ziemnicka, K. (2020). Effect of Central Obesity and Hyperandrogenism on Selected Inflammatory Markers in Patients with PCOS: A WHtR-Matched Case-Control Study. Journal Of Clinical Medicine, 9(9), 3024. https://doi.org/10.3390/jcm9093024
Manrique-Cáceres, J., Rurush Asencio, R., & Castillo Picón, J. (2024). Exportaciones, Inversión y Empleo y su Relación con el Crecimiento Económico del Perú, 1980 – 2021. Estudios Y Perspectivas Revista Científica Y Académica , 4(1), 2530–2546. https://doi.org/10.61384/r.c.a.v4i1.212
Franco Gallegos , L. I., Aguirre Chávez , J. F., Robles Hernández, G. S. I., Montes Mata, K. J., & Ponce de León, A. C. (2024). Efectos diferenciales del ejercicio aeróbico y el entrenamiento de fuerza en marcadores biológicos de salud en adultos mayores. Revista Científica De Salud Y Desarrollo Humano, 5(2), 249–273. https://doi.org/10.61368/r.s.d.h.v5i2.135
Fernández, A. (2023). The Social Impact of Independent Audiovisual Production in the Age of social media: A Case Study in Zamora, Ecuador. Revista Veritas De Difusão Científica, 4(1), 161–180. https://doi.org/10.61616/rvdc.v4i1.42
Fernández C., F. (2024). Determinación De Erodabilidad En Áreas De Influencia Cuenca Poopo Región Andina De Bolivia. Horizonte Académico, 4(4), 63–78. Recuperado a partir de https://horizonteacademico.org/index.php/horizonte/article/view/19
Medina Nolasco, E. K., Mendoza Buleje, E. R., Vilca Apaza, G. R., Mamani Fernández, N. N., & Alfaro Campos, K. (2024). Tamizaje de cáncer de cuello uterino en mujeres de una región Andina del Perú. Arandu UTIC, 11(1), 50–63. https://doi.org/10.69639/arandu.v11i1.177
Da Silva Santos , F., & López Vargas , R. (2020). Efecto del Estrés en la Función Inmune en Pacientes con Enfermedades Autoinmunes: una Revisión de Estudios Latinoamericanos. Revista Científica De Salud Y Desarrollo Humano, 1(1), 46–59. https://doi.org/10.61368/r.s.d.h.v1i1.9
Kałużna, M., Człapka-Matyasik, M., Wachowiak-Ochmańska, K., Moczko, J., Kaczmarek, J., Janicki, A., Piątek, K., Ruchała, M., & Ziemnicka, K. (2020). Effect of Central Obesity and Hyperandrogenism on Selected Inflammatory Markers in Patients with PCOS: A WHtR-Matched Case-Control Study. Journal Of Clinical Medicine, 9(9), 3024. https://doi.org/10.3390/jcm9093024
Kamrul-Hasan, A. B. M., & Aalpona, F. T. Z. (2021). Neck circumference as a predictor of obesity and metabolic syndrome in bangladeshi women with polycystic ovary syndrome. Indian Journal Of Endocrinology And Metabolism, 25(5), 226-231. https://doi.org/10.4103/ijem.ijem_119_21
Karsten, M. D. A., Wekker, V., Groen, H., Painter, R. C., Mol, B. W. J., Laan, E. T. M., Roseboom, T. J., & Hoek, A. (2021). The role of PCOS in mental health and sexual function in women with obesity and a history of infertility. Human Reproduction Open, 2021(4). https://doi.org/10.1093/hropen/hoab038
Liu, C., Ding, L., Yang, H., & Chen, Z. (2022). Neck circumference is independently associated with metabolic syndrome in women with polycystic ovary syndrome. Endocrine Journal, 69(7), 809-818. https://doi.org/10.1507/endocrj.ej21-0761
Mansour, A., Noori, M., Hakemi, M. S., Haghgooyan, Z., Mohajeri-Tehrani, M. R., Mirahmad, M., & Sajjadi-Jazi, S. M. (2024). Hyperandrogenism and anthropometric parameters in women with polycystic ovary syndrome. BMC Endocrine Disorders, 24(1). https://doi.org/10.1186/s12902-024-01733-y
Moran, L. J., Tassone, E. C., Boyle, J., Brennan, L., Harrison, C. L., Hirschberg, A. L., Lim, S., Marsh, K., Misso, M. L., Redman, L., Thondan, M., Wijeyaratne, C., Garad, R., Stepto, N. K., & Teede, H. J. (2020). Evidence summaries and recommendations from the international evidence‐based guideline for the assessment and management of polycystic ovary syndrome: Lifestyle management. Obesity Reviews, 21(10). https://doi.org/10.1111/obr.13046
Neubronner, S. A., Indran, I. R., Chan, Y. H., Thu, A. W. P., & Yong, E. (2021). Effect of body mass index (BMI) on phenotypic features of polycystic ovary syndrome (PCOS) in Singapore women: a prospective cross-sectional study. BMC Women S Health, 21(1). https://doi.org/10.1186/s12905-021-01277-6
Persson, S., Ubhayasekera, K. A., Bergquist, J., Turkmen, S., Poromaa, I. S., & Elenis, E. (2022). Hyperandrogenic Symptoms Are a Persistent Suffering in Midlife Women with PCOS; a Prospective Cohort Study in Sweden. Biomedicines, 11(1), 96. https://doi.org/10.3390/biomedicines11010096
Pirotta, S., Joham, A., Grieger, J. A., Tay, C. T., Bahri-Khomami, M., Lujan, M., Lim, S. S., & Moran, L. J. (2020). Obesity and the Risk of Infertility, Gestational Diabetes, and Type 2 Diabetes in Polycystic Ovary Syndrome. Seminars In Reproductive Medicine, 38(06), 342-351. https://doi.org/10.1055/s-0041-1726866
Pundir, C., Deswal, R., Narwal, V., & Dang, A. (2020). The Prevalence of Polycystic Ovary Syndrome: A Brief Systematic Review. Journal Of Human Reproductive Sciences, 13(4), 261. https://doi.org/10.4103/jhrs.jhrs_95_18
Sánchez-Ferrer, M. L., Arense-Gonzalo, J. J., Prieto-Sánchez, M. T., Gómez-Carrascosa, I., Hernández-Peñalver, A. I., Mendiola, J., & Torres-Cantero, A. M. (2021). Anthropometric Characteristics of Polycystic Ovary Syndrome and Their Associations with Insulin Resistance and Lipid Profile. Applied Sciences, 11(12), 5395. https://doi.org/10.3390/app11125395
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020). Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome. The Journal Of Clinical Endocrinology & Metabolism, 105(10), 3346-3360. https://doi.org/10.1210/clinem/dgaa425
Shirazi, F. K. H., Khodamoradi, Z., & Jeddi, M. (2021). Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS). BMC Endocrine Disorders, 21(1). https://doi.org/10.1186/s12902-021-00710-z
Szczuko, M., Kikut, J., Szczuko, U., Szydłowska, I., Nawrocka-Rutkowska, J., Ziętek, M., Verbanac, D., & Saso, L. (2021). Nutrition Strategy and Life Style in Polycystic Ovary Syndrome—Narrative Review. Nutrients, 13(7), 2452. https://doi.org/10.3390/nu13072452
Teede, H. J., Tay, C. T., Laven, J. J. E., Dokras, A., Moran, L. J., Piltonen, T. T., Costello, M. F., Boivin, J., Redman, L. M., Boyle, J. A., Norman, R. J., Mousa, A., Joham, A. E., Arlt, W., Azziz, R., Balen, A., Bedson, L., Berry, L., Boivin, J., . . . Tan, K. (2023). Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. European Journal Of Endocrinology, 189(2), G43-G64. https://doi.org/10.1093/ejendo/lvad096
Yang, J., & Chen, C. (2024). Hormonal changes in PCOS. Journal Of Endocrinology, 261(1). https://doi.org/10.1530/joe-23-0342
Yang, S., Liu, C., Ma, S., Chang, W., Chen, Y., Lee, W., & Wang, P. (2022). Association between Pre-Pregnancy Overweightness/Obesity and Pregnancy Outcomes in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis. International Journal Of Environmental Research And Public Health, 19(15), 9094. https://doi.org/10.3390/ijerph19159094
Zhang, M., Wang, Y., Di, J., Zhang, X., Liu, Y., Zhang, Y., Li, B., Qi, S., Cao, X., Liu, L., Liu, S., & Xu, F. (2024). High coverage of targeted lipidomics revealed lipid changes in the follicular fluid of patients with insulin-resistant polycystic ovary syndrome and a positive correlation between plasmalogens and oocyte quality. Frontiers In Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1414289
Zheng, L., Yang, L., Guo, Z., Yao, N., Zhang, S., & Pu, P. (2024). Obesity and its impact on female reproductive health: unraveling the connections. Frontiers In Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1326546
Derechos de autor 2025 Jonathan Michael Vélez Torres, Angie Anahis Aspiazu Morocho, Pedro Sebastián Espinoza Guamán
Esta obra está bajo licencia internacional Creative Commons Reconocimiento 4.0.
.png)
.png)
1.png)
